Canada's provinces plan to pool drug purchases

The leaders of Canada's 13 provinces and territories unveiled a plan Thursday to pool their purchases of generic drugs to gain a bulk discount amid concern over soaring healthcare costs.

The premiers are meeting this week in Halifax to discuss pan-Canadian issues such as soaring healthcare and linking up the nation's fractured .

They released a report at the summit that calls for bulk drug purchases starting as early as September, but it did not outline what the expected savings would be.

Previous attempts by the provinces to cooperate on healthcare, however, have failed.

add to favorites email to friend print save as pdf

Related Stories

US lawmakers reject Canada drug purchases

Oct 20, 2011

The US Senate Thursday rejected a measure that would have enabled Americans to buy prescription drugs in Canada in a bid to reduce the costs of their health care.

Myth busted: Some drugs do cost more in Canada

Sep 29, 2008

(PhysOrg.com) -- Canada may be recognized as a bargain hunters' paradise for prescription drugs, but a new U of T study suggests that many generic medications may be more expensive in Canada than in the U.S. The uninsured ...

Impact of Canada's Common Drug Review on drug listing

Oct 24, 2011

The number of drugs covered by public drug plans decreased substantially after Canada's Common Drug Review was introduced in 2003, and new drugs were listed more quickly in several of the smaller provinces, found a study ...

Recommended for you

Expression of privilege in vaccine refusal

7 hours ago

Not all students returning to school this month will be up to date on their vaccinations. A new study conducted by Jennifer Reich, a researcher at the University of Colorado Denver, shows that the reasons why children may ...

Using computers to design drugs

Aug 22, 2014

Designing a new medicine is an expensive and time consuming business. Typically it takes around $2 billion and ten years for a new drug to move from its initial design in the lab, to the clinic. All the ...

Lilly psoriasis drug fares well in late-stage test

Aug 22, 2014

Drugmaker Eli Lilly and Co. said its potential psoriasis treatment fared better than both a fake drug and a competitor's product during late-stage testing on patients with the most common form of the skin disease.

User comments